Germin8 Ventures
  • Team
  • Companies
  • Strategy
  • Insights
Select Page
Crunchbase Strategy Session: Germin8 Ventures Positions Itself To Invest In Food As Medicine Startups

Crunchbase Strategy Session: Germin8 Ventures Positions Itself To Invest In Food As Medicine Startups

Feb 11, 2021

Germin8 Ventures Names Dr. Ashlie L. Burkart as Chief Scientific Officer

Germin8 Ventures Names Dr. Ashlie L. Burkart as Chief Scientific Officer

Feb 11, 2021

Recent Posts

  • URUS Agrees to Acquire AgriWebb, Expanding its Digital and Data Capabilities Across Global Beef Production and Supply Chains
  • Former U.S. Secretary of Agriculture Mike Johanns Joins Avalo as Strategic Advisor to Advance ‘Farmer First’ Revolution
  • Alloy Therapeutics Secures $1B Valuation
  • Kanvas Biosciences Secures $48M Series A to Deliver Novel Microbiome Therapeutics to Cancer Patients
  • Alpine Bio Selected for Mondelēz CoLab Tech 2026 to Advance High-Protein Snack Development

Recent Comments

    Archives

    • July 2026
    • August 2024
    • June 2024
    • October 2023
    • September 2023
    • August 2023
    • April 2023
    • June 2022
    • July 2021
    • February 2021
    • January 2021
    • December 2020
    • October 2020
    • July 2020
    • April 2020

    Categories

    • Featured Insights
    • Insights
    • Uncategorized

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    Germin8 Ventures icon

    BIG VISIONS WITH BOLD STRATEGIES & PURPOSE

    © 2025 Germin8 Ventures, LLC. All rights reserved.

    • Team
    • Companies
    • Strategy
    • Insights
    • Contact Us

    Global Offices
    Chicago, IL
    San Francisco, CA
    Herzliya, Israel